These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29355688)

  • 1. Metabolomics profiling of steatosis progression in HepaRG
    Cuykx M; Claes L; Rodrigues RM; Vanhaecke T; Covaci A
    Toxicol Lett; 2018 Apr; 286():22-30. PubMed ID: 29355688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells.
    Rodrigues RM; Branson S; De Boe V; Sachinidis A; Rogiers V; De Kock J; Vanhaecke T
    Arch Toxicol; 2016 Mar; 90(3):677-89. PubMed ID: 25716160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective assessment of valproate sodium-induced hepatotoxicity with UPLC-MS and (1)HNMR-based metabonomics approach.
    Huo T; Chen X; Lu X; Qu L; Liu Y; Cai S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():109-16. PubMed ID: 25168794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Signature of Ethanol-Induced Hepatotoxicity in HepaRG Cells by Liquid Chromatography-Mass Spectrometry-Based Untargeted Metabolomics.
    Iturrospe E; da Silva KM; Robeyns R; van de Lavoir M; Boeckmans J; Vanhaecke T; van Nuijs ALN; Covaci A
    J Proteome Res; 2022 Apr; 21(4):1153-1166. PubMed ID: 35274962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG® cells.
    Cuykx M; Beirnaert C; Rodrigues RM; Laukens K; Vanhaecke T; Covaci A
    Toxicol Appl Pharmacol; 2019 Sep; 379():114666. PubMed ID: 31323262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
    Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Kim DJ; Suk KT
    Life Sci; 2023 Jun; 322():121626. PubMed ID: 37003543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.
    Zhang LF; Liu LS; Chu XM; Xie H; Cao LJ; Guo C; A JY; Cao B; Li MJ; Wang GJ; Hao HP
    Acta Pharmacol Sin; 2014 Mar; 35(3):363-72. PubMed ID: 24442146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
    Kumar BS; Chung BC; Kwon OS; Jung BH
    J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple transcriptomic signature able to predict drug-induced hepatic steatosis.
    Benet M; Moya M; Donato MT; Lahoz A; Hervás D; Guzmán C; Gómez-Lechón MJ; Castell JV; Jover R
    Arch Toxicol; 2014 Apr; 88(4):967-82. PubMed ID: 24469900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.
    Younossi ZM; Karrar A; Pierobon M; Birerdinc A; Stepanova M; Abdelatif D; Younoszai Z; Jeffers T; Felix S; Jeiran K; Hodge A; Zhou W; Monge F; Alaparthi L; Chandhoke V; Goodman ZD; Petricoin EF
    BMC Med; 2018 Sep; 16(1):170. PubMed ID: 30205811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic signature of HepaRG cells exposed to ethanol and tumor necrosis factor alpha to study alcoholic steatohepatitis by LC-MS-based untargeted metabolomics.
    Iturrospe E; Robeyns R; da Silva KM; van de Lavoir M; Boeckmans J; Vanhaecke T; van Nuijs ALN; Covaci A
    Arch Toxicol; 2023 May; 97(5):1335-1353. PubMed ID: 36826472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine.
    Lee MS; Jung BH; Chung BC; Cho SH; Kim KY; Kwon OS; Nugraha B; Lee YJ
    Int J Toxicol; 2009; 28(5):392-404. PubMed ID: 19605889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.
    Nault R; Fader KA; Kopec AK; Harkema JR; Zacharewski TR; Luyendyk JP
    Toxicol Sci; 2016 Dec; 154(2):381-391. PubMed ID: 27613713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study.
    Jin R; Banton S; Tran VT; Konomi JV; Li S; Jones DP; Vos MB
    J Pediatr; 2016 May; 172():14-19.e5. PubMed ID: 26858195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.
    Nault R; Fader KA; Ammendolia DA; Dornbos P; Potter D; Sharratt B; Kumagai K; Harkema JR; Lunt SY; Matthews J; Zacharewski T
    Toxicol Sci; 2016 Dec; 154(2):253-266. PubMed ID: 27562557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease.
    Puchalska P; Crawford PA
    Methods Mol Biol; 2019; 1996():259-272. PubMed ID: 31127561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.